Vestis Corp. <VSTS.N>: Barclays raises target price to $11 from $9
VSTS•Related News

Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
KPTI•

Diodes Incorporated Announces Proposed Private Placement Of $325 Million Of Convertible Senior Notes
DIOD•

Parabilis Medicines Reports Second Quarter 2026 Financial Results And Provides Business Updates
PBLS•

Chicago Atlantic BDC Q2 income falls sequentially on repayments
CCAP•

Bragg Gaming says 2Q26 revenue falls 12% on Netherlands legacy contract roll-off, other market softness
BRAG•